To examine the cellular and molecular impacts of diabetic metabolic disorders on intervertebral disc degeneration (IDD) and to elucidate the mechanisms involved.
Key Findings:
Diabetes mellitus is significantly associated with the onset and progression of intervertebral disc degeneration.
Metabolic disorders and vascular lesions from hyperglycemia contribute to accelerated IDD.
Advanced glycation end products (AGEs) and oxidative stress play critical roles in the degeneration process.
Diabetic patients experience more severe and complex spinal degeneration.
Interpretation:
Understanding the connection between diabetes and IDD is crucial for developing new prevention and treatment strategies, as current research lacks comprehensive integration of findings.
Limitations:
Most studies focus on individual pathways rather than a holistic view of the mechanisms involved.
The precise molecular mechanisms of diabetes-induced IDD remain inadequately understood.
Conclusion:
The review provides a theoretical framework and practical recommendations for targeted metabolic therapy strategies to manage spinal degenerative disorders and improve patient quality of life.
The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.
